SEC Form 4 · accession 0001140361-26-026779
CG Oncology, Inc. · CGON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Guan-Chyun Liu
Director
Period of report
Jun 25, 2026
Accepted (ET)
Jun 29, 2026 · 5:26 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001991792
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 25, 2026 | P | 371,085 | $66.87 | A | 1,886,236 | I | By Seven Fleet Partners LP |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person, as the managing member of Seven Fleet Advisors, LLC, the investment manager of Seven Fleet Partners, LP, may be deemed to beneficially own the shares of Common Stock held by Seven Fleet Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.